MEA G-CSF PEG-G-CSF Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	217 Pages	Data Bridge Market Research	December, 2022	DAABD17635873

Best Price Guarantee
Price	from $3,500
Length	217 Pages
Publisher	Data Bridge Market Research
Published Date	December, 2022
SKU	DAABD17635873

MEA G-CSF PEG-G-CSF Market - Industry Trends and Forecast to 2030

Middle East and Africa G-CSF/ PEG-G-CSF market is projected to register a substantial CAGR of 4.1% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentations

Middle East Africa G-CSF/PEG-G-CSF Market, By Indication (Neutropenia, Oncology, Chronic and Autoimmune Disease, Blood Disorders, Growth Harmony Deficiency and Others), Dosage (Mono and Combination), Route Of Administration (Intravenous, Subcutaneous), Packaging (Single Use Vials and Pre Filled Syringes), End User (Hospitals and Clinics, Research and Academic Institutes, Ambulatory Surgical Centers and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy and Others), Country (South Africa, Saudi Arabia, Egypt, Israel, UAE, Kuwait, Oman, and Rest of Middle East and Africa) Industry Trends and Forecast to 2030

Some of the major factors contributing to the growth of the Middle East and Africa G-CSF/PEG-G-CSF market are:
• Growing incidences of blood cancers and cancer diseases
• Increasing cases of febrile neutropenia

Market Players

The key market players operating in the Middle East and Africa G-CSF/PEG-G-CSF market are listed below:
• Lupin
• BIOSIDUS
• USV Private Limited
• Viatris Inc.
• Biocon
• Fresenius Kabi AG
• Amgen Inc.
• Pfizer Inc.
• Sandoz International GmbH
• Dr. Reddy’s Laboratories Ltd.
• Accord Healthcare
• NAPP PHARMACEUTICALS LIMITED.
• Intas Pharmaceuticals Ltd.
• Mundipharma International
• Teva Pharmaceutical Industries Ltd.
• Kyowa Kirin Co., Ltd.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Middle East & Africa G-csf / Peg-g-csf Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market End User Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter’s Five Forces; 4.3 Middle East & Africa G-csf/Peg-g-csf Market: Mergers And Acquisition; 4.4 Middle East & Africa G-csf / Peg-g-csf Market; 4.5 Strategies To The Enter The Market; 4.5.1 Joint Venture (Partnerships):; 4.5.2 Acquisition:; 4.5.3 Line Expansion Via Collaboration:; 4.5.4 Product Approval:; 4.5.5 Product Launch:; 4.5.6 Geographic Expansion:; 4.5.7 Cost Leadership:; 4.5.8 Product Development:; 4.6 Middle East & Africa G-csf / Peg-g-csf Market, Industry Insights; 4.6.1 Patent Analysis; 4.6.2 Drug Treatment Rate By Matured Markets; 4.6.3 Demographic Trends: Impacts On All Incidence Rates; 4.6.4 Therapeutic Assessment; 4.6.5 Key Pricing Strategies; 4.6.6 Key Patient Enrollment Strategies; 4.6.7 Conclusion; 4.7 Pipeline Analysis For Middle East & Africa G-csf / Peg-g-csf Market
5 Epidemiology
6 Middle East & Africa G-csf / Peg-g-csf Market: Regulations
7 Market Overview: 7.1 Drivers; 7.1.1 Growing Incidences Of Blood Cancers And Cancer Diseases; 7.1.2 Rising Incidences Of Autoimmune Disorders; 7.1.3 Increasing Cases Of Febrile Neutropenia; 7.1.4 Increasing Awareness About Filgrastim And Pegfilgrastim; 7.2 Restrain; 7.2.1 Stringent Governmental Regulations; 7.2.2 Availability Of Alternatives For The Chemotherapy; 7.3 Opportunities; 7.3.1 The Use Of Biosimilars Helps Reduce Healthcare Costs For Patients; 7.3.2 Cost-effectiveness And Patent Expiry Of Biological Products; 7.4 Challenges; 7.4.1 The High Cost Associated With Branded Biologics And Improved Chemotherapy; 7.4.2 The Multiple Side Effects Of G-csf
8 Middle East & Africa G-csf/ Peg-g-csf Market, By Indication: 8.1 Overview; 8.2 Neutropenia; 8.2.1 Chemotherapy Induced Febrile Neutropenia (Myelosuppressive Chemotherapy Treatment); 8.2.2 Severe Chronic Neutropenia; 8.2.3 Radiotherapy Induced Neutropenia; 8.2.4 Neutropenia In Hiv Patients; 8.2.5 Clozapine Induced Neutropenia; 8.2.6 Neutropenia In Hepatitis C Patients; 8.2.7 Congenital Neutropenia; 8.3 Oncology; 8.3.1 Acute Myeloid Leukemia Receiving Consolidation Chemotherapy; 8.3.2 Others; 8.4 Chronic And Auto Immune Diseases; 8.5 Blood Disorders; 8.6 Growth Hormone Deficiency; 8.7 Others
9 Middle East & Africa G-csf/ Peg-g-csf Market, By Dosage: 9.1 Overview; 9.2 Mono; 9.3 Combination
10 Middle East & Africa G-csf/ Peg-g-csf Market, By Route Of Administration: 10.1 Overview; 10.2 Subcutaneous; 10.3 Intravenous
11 Middle East & Africa G-csf/ Peg-g-csf Market, By Packaging: 11.1 Overview; 11.2 Pre Filled Syringes; 11.3 Single Use Vials
12 Middle East & Africa G-csf/ Peg-g-csf Market, By End User: 12.1 Overview; 12.2 Hospitals And Clinics; 12.3 Research & Academic Institutes; 12.4 Ambulatory Surgical Centers; 12.5 Others
13 Middle East & Africa G-csf/ Peg-g-csf Market, By Distribution Channel: 13.1 Overview; 13.2 Hospitals Pharmacy; 13.3 Retail Pharmacy; 13.4 Online Pharmacy; 13.5 Others
14 Middle East & Africa G-csf/Peg-g-csf Market, By Region: 14.1 Middle East And Africa; 14.1.1 South Africa; 14.1.2 Saudi Arabia; 14.1.3 Egypt; 14.1.4 Israel; 14.1.5 Uae; 14.1.6 Kuwait; 14.1.7 Oman
15 Middle East & Africa G-csf / Peg-g-csf Market, Company Landscape: 15.1 Company Share Analysis: Middle East & Africa
16 Swot Analysis
17 Company Profile: 17.1 Pfizer Inc.; 17.1.1 Company Snapshot; 17.1.2 Revenue Analysis; 17.1.3 Company Share Analysis; 17.1.4 Product Portfolio; 17.1.5 Recent Developments; 17.2 Viatris Inc.; 17.2.1 Company Snapshot; 17.2.2 Revenue Analysis; 17.2.3 Company Share Analysis; 17.2.4 Product Portfolio; 17.2.5 Recent Development; 17.3 Amgen Inc.; 17.3.1 Company Snapshot; 17.3.2 Revenue Analysis; 17.3.3 Company Share Analysis; 17.3.4 Product Portfolio; 17.3.5 Recent Developments; 17.4 Stada Arzeneimittel Ag; 17.4.1 Company Snapshot; 17.4.2 Company Share Analysis; 17.4.3 Product Portfolio; 17.4.4 Recent Development; 17.5 Teva Pharmaceutical Industries Ltd.; 17.5.1 Company Snapshot; 17.5.2 Revenue Analysis; 17.5.3 Company Share Analysis; 17.5.4 Product Portfolio; 17.5.5 Recent Developments; 17.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd.; 17.6.1 Company Snapshot; 17.6.2 Product Portfolio; 17.6.3 Recent Developments; 17.7 Accord Healthcare; 17.7.1 Company Snapshot; 17.7.2 Product Portfolio; 17.7.3 Recent Developments; 17.8 Amneal Pharmaceuticals Llc.; 17.8.1 Company Snapshot; 17.8.2 Revenue Analysis; 17.8.3 Product Portfolio; 17.8.4 Recent Developments; 17.9 Apotex Inc.; 17.9.1 Company Snapshot; 17.9.2 Product Portfolio; 17.9.3 Recent Development; 17.10 Biocon; 17.10.1 Company Snapshot; 17.10.2 Revenue Analysis; 17.10.3 Product Portfolio; 17.10.4 Recent Development; 17.11 Bio Sidus; 17.11.1 Company Snapshot; 17.11.2 Product Portfolio; 17.11.3 Recent Developments; 17.12 Cadila Pharmaceuticals; 17.12.1 Company Snapshot; 17.12.2 Product Portfolio; 17.12.3 Recent Developments; 17.13 Coherus Biosciences; 17.13.1 Company Snapshot; 17.13.2 Revenue Analysis; 17.13.3 Product Portfolio; 17.13.4 Recent Development; 17.14 Dr. Reddy’s Laboratories Ltd; 17.14.1 Company Snapshot; 17.14.2 Revenue Analysis; 17.14.3 Product Portfolio; 17.14.4 Recent Developments; 17.15 Fresenius Kabi Ag; 17.15.1 Company Snapshot; 17.15.2 Product Portfolio; 17.15.3 Recent Development; 17.16 Gennova Biopharmaceuticals Limited; 17.16.1 Company Snapshot; 17.16.2 Product Portfolio; 17.16.3 Recent Developments; 17.17 Hangzhou Jiuyuan Gene Engineering Co., Ltd.; 17.17.1 Company Snapshot; 17.17.2 Product Portfolio; 17.17.3 Recent Developments; 17.18 Intas Pharmaceuticals Ltd.; 17.18.1 Company Snapshot; 17.18.2 Product Portfolio; 17.18.3 Recent Development; 17.19 Kashiv Biosciences, Llc.; 17.19.1 Company Snapshot; 17.19.2 Product Portfolio; 17.19.3 Recent Development; 17.20 Kyowa Kirin Co., Ltd.; 17.20.1 Company Snapshot; 17.20.2 Revenue Analysis; 17.20.3 Product Portfolio; 17.20.4 Recent Development; 17.21 Lupin; 17.21.1 Company Snapshot; 17.21.2 Revenue Analysis; 17.21.3 Product Portfolio; 17.21.4 Recent Development; 17.22 Mundipharma International.; 17.22.1 Company Snapshot; 17.22.2 Product Portfolio; 17.22.3 Recent Development; 17.23 Napp Pharmaceuticals Limited; 17.23.1 Company Snapshot; 17.23.2 Product Portfolio; 17.23.3 Recent Development; 17.24 Reliance Life Sciences; 17.24.1 Company Snapshot; 17.24.2 Product Portfolio; 17.24.3 Recent Developments; 17.25 Sandoz International Gmbh; 17.25.1 Company Snapshot; 17.25.2 Revenue Analysis; 17.25.3 Product Portfolio; 17.25.4 Recent Developments; 17.26 Spectrum Pharmaceuticals, Inc.; 17.26.1 Company Snapshot; 17.26.2 Product Portfolio; 17.26.3 Recent Development; 17.27 Usv Private Limited; 17.27.1 Company Snapshot; 17.27.2 Product Portfolio; 17.27.3 Recent Developments
18 Questionnaire
19 Related Reports
List Of Tables: Table 1 Below Are The Rules And Regulations To Get Approval For Use In The Market:; Table 2 Middle East & Africa G-csf/ Peg-g-csf Market, By Indication, 2021-2030 (Usd Million); Table 3 Middle East & Africa Neutropenia In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 4 Middle East & Africa Neutropenia In G-csf/ Peg-g-csf Market, By Indication, 2021-2030 (Usd Million); Table 5 Middle East & Africa Oncology In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 6 Middle East & Africa Oncology In G-csf/ Peg-g-csf Market, By Indication, 2021-2030 (Usd Million); Table 7 Middle East & Africa Chronic And Auto Immune Diseases In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 8 Middle East & Africa Blood Disorders In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 9 Middle East & Africa Growth Hormone Deficiency In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 10 Middle East & Africa Others In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 11 Middle East & Africa G-csf/ Peg-g-csf Market, By Dosage, 2020-2029 (Usd Million); Table 12 Middle East & Africa Mono In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 13 Middle East & Africa Combination In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 14 Middle East & Africa G-csf/ Peg-g-csf Market, By Route Of Administration, 2020-2029 (Usd Million); Table 15 Middle East & Africa Subcutaneous In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 16 Middle East & Africa Intravenous In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 17 Middle East & Africa G-csf/ Peg-g-csf Market, By Packaging, 2020-2029 (Usd Million); Table 18 Middle East & Africa Pre Filled Syringes In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 19 Middle East & Africa Single Use Vials In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 20 Middle East & Africa G-csf/ Peg-g-csf Market, By End User, 2020-2029 (Usd Million); Table 21 Middle East & Africa Hospitals And Clinics In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 22 Middle East & Africa Research & Academic Institutes In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 23 Middle East & Africa Ambulatory Surgical Centers In G-csf/ Peg-g-csfmarket, By Region, 2020-2029 (Usd Million); Table 24 Middle East & Africa Others In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 25 Middle East & Africa G-csf/ Peg-g-csf Market, By Distribution Channel, 2020-2029 (Usd Million); Table 26 Middle East & Africa Hospitals Pharmacy In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 27 Middle East & Africa Retail Pharmacy In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 28 Middle East & Africa Online Pharmacy In G-csf/ Peg-g-csfmarket, By Region, 2020-2029 (Usd Million); Table 29 Middle East & Africa Others In G-csf/ Peg-g-csf Market, By Region, 2020-2029 (Usd Million); Table 30 Middle East And Africa G-csf / Peg-g-csf Market, 2020-2030 (Usd Million); Table 31 Middle East And Africa G-csf / Peg-g-csf Market, 2020-2030 (Usd Million); Table 32 Middle East And Africa G-csf / Peg-g-csf Market, By Country, 2020-2030 (Usd Million); Table 33 Middle East And Africa G-csf / Peg-g-csf Market, By Indication, 2020-2030 (Usd Million); Table 34 Middle East And Africa Neutropenia In G-csf / Peg-g-csf Market, By Indication, 2020-2030 (Usd Million); Table 35 Middle East And Africa Oncology In G-csf / Peg-g-csf Market, By Indication, 2020-2030 (Usd Million); Table 36 Middle East And Africa G-csf / Peg-g-csf Market, By Dosage, 2020-2030 (Usd Million); Table 37 Middle East And Africa G-csf / Peg-g-csf Market, By Route Of Administration, 2020-2030 (Usd Million); Table 38 Middle East And Africa G-csf / Peg-g-csf Market, By Packaging, 2020-2030 (Usd Million); Table 39 Middle East And Africa G-csf / Peg-g-csf Market, By End User, 2020-2030 (Usd Million); Table 40 Middle East And Africa G-csf / Peg-g-csf Market, By Distribution Channel, 2020-2030 (Usd Million); Table 41 South Africa G-csf / Peg-g-csf Market, By Indication, 2020-2030 (Usd Million); Table 42 South Africa Neutropenia In G-csf / Peg-g-csf Market, By Indication, 2020-2030 (Usd Million); Table 43 South Africa Oncology In G-csf / Peg-g-csf Market, By Indication, 2020-2030 (Usd Million); Table 44 South Africa G-csf / Peg-g-csf Market, By Dosage, 2020-2030 (Usd Million); Table 45 South Africa Mono In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 46 South Africa G-csf / Peg-g-csf Market, By Route Of Administration, 2020-2030 (Usd Million); Table 47 South Africa Subcutaneous In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 48 South Africa Intravenous In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 49 South Africa G-csf / Peg-g-csf Market, By Packaging, 2020-2030 (Usd Million); Table 50 South Africa Pre Filled Syringes In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 51 South Africa Single Use Vials In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 52 South Africa G-csf / Peg-g-csf Market, By End User, 2020-2030 (Usd Million); Table 53 South Africa Hospital And Clinics In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 54 South Africa Hospital And Clinics In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 55 South Africa Hospital And Clinics In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 56 South Africa Research And Academic Institutes In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 57 South Africa Research And Academic Institutes In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 58 South Africa Research And Academic Institutes In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 59 South Africa Ambulatory Surgical Centers In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 60 South Africa Ambulatory Surgical Centers In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 61 South Africa Ambulatory Surgical Centers In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 62 South Africa G-csf / Peg-g-csf Market, By Distribution Channel, 2020-2030 (Usd Million); Table 63 South Africa Hospital Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 64 South Africa Hospital Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 65 South Africa Hospital Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 66 South Africa Retail Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 67 South Africa Retail Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 68 South Africa Retail Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 69 South Africa Online Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 70 South Africa Online Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 71 South Africa Online Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 72 Saudi Arabia G-csf / Peg-g-csf Market, By Indication, 2020-2030 (Usd Million); Table 73 Saudi Arabia Neutropenia In G-csf / Peg-g-csf Market, By Indication, 2020-2030 (Usd Million); Table 74 Saudi Arabia Oncology In G-csf / Peg-g-csf Market, By Indication, 2020-2030 (Usd Million); Table 75 Saudi Arabia G-csf / Peg-g-csf Market, By Dosage, 2020-2030 (Usd Million); Table 76 Saudi Arabia Mono In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 77 Saudi Arabia G-csf / Peg-g-csf Market, By Route Of Administration, 2020-2030 (Usd Million); Table 78 Saudi Arabia Subcutaneous In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 79 Saudi Arabia G-csf / Peg-g-csf Market, By Packaging, 2020-2030 (Usd Million); Table 80 Saudi Arabia Pre Filled Syringes In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 81 Saudi Arabia G-csf / Peg-g-csf Market, By End User, 2020-2030 (Usd Million); Table 82 Saudi Arabia Hospital And Clinics In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 83 Saudi Arabia Hospital And Clinics In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 84 Saudi Arabia Hospital And Clinics In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 85 Saudi Arabia Research And Academic Institutes In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 86 Saudi Arabia Research And Academic Institutes In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 87 Saudi Arabia Research And Academic Institutes In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 88 Saudi Arabia Ambulatory Surgical Centers In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 89 Saudi Arabia Ambulatory Surgical Centers In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 90 Saudi Arabia Ambulatory Surgical Centers In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 91 Saudi Arabia G-csf / Peg-g-csf Market, By Distribution Channel, 2020-2030 (Usd Million); Table 92 Saudi Arabia Hospital Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 93 Saudi Arabia Hospital Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 94 Saudi Arabia Hospital Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 95 Saudi Arabia Retail Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 96 Saudi Arabia Retail Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 97 Saudi Arabia Retail Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 98 Saudi Arabia Online Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 99 Saudi Arabia Online Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 100 Saudi Arabia Online Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 101 Egypt G-csf / Peg-g-csf Market, By Indication, 2020-2030 (Usd Million); Table 102 Egypt Neutropenia In G-csf / Peg-g-csf Market, By Indication, 2020-2030 (Usd Million); Table 103 Egypt Oncology In G-csf / Peg-g-csf Market, By Indication, 2020-2030 (Usd Million); Table 104 Egypt G-csf / Peg-g-csf Market, By Dosage, 2020-2030 (Usd Million); Table 105 Egypt Mono In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 106 Egypt G-csf / Peg-g-csf Market, By Route Of Administration, 2020-2030 (Usd Million); Table 107 Egypt Subcutaneous In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 108 Egypt G-csf / Peg-g-csf Market, By Packaging, 2020-2030 (Usd Million); Table 109 Egypt Pre Filled Syringes In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 110 Egypt G-csf / Peg-g-csf Market, By End User, 2020-2030 (Usd Million); Table 111 Egypt Hospital And Clinics In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 112 Egypt Hospital And Clinics In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 113 Egypt Hospital And Clinics In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 114 Egypt Research And Academic Institutes In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 115 Egypt Research And Academic Institutes In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 116 Egypt Research And Academic Institutes In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 117 Egypt Ambulatory Surgical Centers In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 118 Egypt Ambulatory Surgical Centers In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 119 Egypt Ambulatory Surgical Centers In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 120 Egypt G-csf / Peg-g-csf Market, By Distribution Channel, 2020-2030 (Usd Million); Table 121 Egypt Hospital Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 122 Egypt Hospital Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 123 Egypt Hospital Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 124 Egypt Retail Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 125 Egypt Retail Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 126 Egypt Retail Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 127 Egypt Online Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 128 Egypt Online Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Asp (Usd); Table 129 Egypt Online Pharmacy In G-csf / Peg-g-csf Market, By Brand, 2020-2030 Volume (Units); Table 130 Israel G-csf / Peg-g-csf Market, By Indication, 2020-2030 (Usd Million); Table 131 Israel Neutropenia In G-csf / Peg-g-csf Market, By Indication, 2020-2030 (Usd Million); Table 132 Israel Oncology In G-csf / Peg-g-csf Market, By Indication, 2020-2030 (Usd Million); Table 133 Israel G-csf / Peg-g-csf Market, By Dosage, 2020-2030 (Usd Million); Table 134 Israel Mono In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 135 Israel G-csf / Peg-g-csf Market, By Route Of Administration, 2020-2030 (Usd Million); Table 136 Israel Subcutaneous In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 137 Israel Intravenous In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 138 Israel G-csf / Peg-g-csf Market, By Packaging, 2020-2030 (Usd Million); Table 139 Israel Pre Filled Syringes In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million); Table 140 Israel G-csf / Peg-g-csf Market, By End User, 2020-2030 (Usd Million); Table 141 Israel Hospital And Clinics In G-csf / Peg-g-csf Market, By Brand, 2020-2030 (Usd Million)
List Of Figures: Figure 1 Middle East & Africa G-csf / Peg-g-csf Market: Segmentation; Figure 2 Middle East & Africa G-csf / Peg-g-csf Market: Data Triangulation; Figure 3 Middle East & Africa G-csf / Peg-g-csf Market: Droc Analysis; Figure 4 Middle East & Africa G-csf / Peg-g-csf Market: Middle East & Africa Vs Regional Market Analysis; Figure 5 Middle East & Africa G-csf / Peg-g-csf Market: Company Research Analysis; Figure 6 Middle East & Africa G-csf / Peg-g-csf Market: Interview Demographics; Figure 7 Middle East & Africa G-csf / Peg-g-csf Market: Dbmr Market Position Grid; Figure 8 Middle East & Africa G-csf / Peg-g-csf Market: Market End User Coverage Grid; Figure 9 Middle East & Africa G-csf / Peg-g-csf Market: Vendor Share Analysis; Figure 10 Middle East & Africa G-csf / Peg-g-csf Market: Segmentation; Figure 11 The Increase In Cancer Prophylaxis In Developed Countries And Initiatives Taken By Governments Are To Drive The Middle East & Africa G-csf / Peg-g-csf Market From 2023 To 2030; Figure 12 Neutropenia Segment Is Expected To Account For The Largest Share Of The Middle East & Africa G-csf / Peg-g-csf Market In 2023 & 2030; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Middle East & Africa G-csf / Peg-g-csf Market; Figure 14 Middle East & Africa G-csf/ Peg-g-csf Market: By Indication Category, 2022; Figure 15 Middle East & Africa G-csf/ Peg-g-csf Market: By Indication Category, 2021-2030 (Usd Million); Figure 16 Middle East & Africa G-csf/ Peg-g-csf Market: By Indication Category, Cagr (2022-2029); Figure 17 Middle East & Africa G-csf/ Peg-g-csf Market: By Indication Category, Lifeline Curve; Figure 18 Middle East & Africa G-csf/ Peg-g-csf Market: By Dosage, 2022; Figure 19 Middle East & Africa G-csf/ Peg-g-csf Market: By Dosage, 2021-2030 (Usd Million); Figure 20 Middle East & Africa G-csf/ Peg-g-csf Market: By Dosage, Cagr (2023-2030); Figure 21 Middle East & Africa G-csf/ Peg-g-csf Market: By Dosage, Lifeline Curve; Figure 22 Middle East & Africa G-csf/ Peg-g-csf Market: By Route Of Administration, 2022; Figure 23 Middle East & Africa G-csf/ Peg-g-csf Market: By Route Of Administration, 2021-2030 (Usd Million); Figure 24 Middle East & Africa G-csf/ Peg-g-csf Market: By Route Of Administration, Cagr (2023-2030); Figure 25 Middle East & Africa G-csf/ Peg-g-csf Market: By Route Of Administration, Lifeline Curve; Figure 26 Middle East & Africa G-csf/ Peg-g-csf Market: By Packaging, 2022; Figure 27 Middle East & Africa G-csf/ Peg-g-csf Market: By Packaging, 2021-2030 (Usd Million); Figure 28 Middle East & Africa G-csf/ Peg-g-csf Market: By Packaging, Cagr (2023-2030); Figure 29 Middle East & Africa G-csf/ Peg-g-csf Market: By Packaging, Lifeline Curve; Figure 30 Middle East & Africa G-csf/ Peg-g-csf Market: By End User, 2022; Figure 31 Middle East & Africa G-csf/ Peg-g-csf Market: By End User, 2021-2030 (Usd Million); Figure 32 Middle East & Africa G-csf/ Peg-g-csf Market: By End User, Cagr (2023-2030); Figure 33 Middle East & Africa G-csf/ Peg-g-csf Market: By End User, Lifeline Curve; Figure 34 Middle East & Africa G-csf/ Peg-g-csf Market: By Distribution Channel, 2022; Figure 35 Middle East & Africa G-csf/ Peg-g-csf Market: By Distribution Channel, 2021-2030 (Usd Million); Figure 36 Middle East & Africa G-csf/ Peg-g-csf Market: By Distribution Channel, Cagr (2023-2030); Figure 37 Middle East & Africa G-csf/ Peg-g-csf Market: By Distribution Channel, Lifeline Curve; Figure 38 Middle East And Africa G-csf/Peg-g-csf Market: Snapshot (2022); Figure 39 Middle East And Africa G-csf/Peg-g-csf Market: By Country (2022); Figure 40 Middle East And Africa G-csf/Peg-g-csf Market: By Country (2022 & 2030); Figure 41 Middle East And Africa G-csf/Peg-g-csf Market: By Country (2022 & 2030); Figure 42 Middle East And Africa G-csf/Peg-g-csf Market: By Indication (2023-2030); Figure 43 Middle East & Africa G-csf / Peg-g-csf Market: Company Share 2022 (%) 171